Funding
Funding not disclosed
Founders
Product
Problem
Early-stage cancer detection often relies on expensive and complex laboratory equipment, limiting accessibility and affordability for widespread screening. This can result in delayed diagnoses and poorer patient outcomes, particularly in resource-constrained settings.
Solution
Epigen manufactures and distributes cancer diagnostic kits and essential research reagents designed to facilitate early-stage cancer detection at an affordable cost. These products aim to provide accessible tools for experimental research and diagnostic testing in laboratories, potentially enabling earlier diagnoses and improved patient care. By focusing on cost-effectiveness, Epigen seeks to broaden the availability of cancer detection technologies.
Target Audience
The primary target audience includes research laboratories and diagnostic testing facilities focused on cancer detection and research.
Features
- Cancer diagnostic kits for early-stage detection
- Essential research reagents for experimental research
- Products designed for cost-effective laboratory testing